Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy

References

1. 1.↵
   2. Wang X,
   3. Li X,
   4. Wei X,
   5. Jiang H,
   6. Lan C,
   7. Yang S, et al.

   PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC. Signal Transduct Target Ther. 2020; 5: 38.

   OpenUrl
2. 2.↵
   2. Houchen CW,
   3. Li M.

   A subset of epithelial cells mimics regulatory T cells and contributes to immune evasion during development of pancreatic adenocarcinoma. BMC Med. 2020; 18: 155.

   OpenUrl
3. 3.↵
   2. Lang M,
   3. Wang X,
   4. Wang H,
   5. Dong J,
   6. Lan C,
   7. Hao J, et al.

   Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. Cancer Lett. 2016; 378: 87–96.

   OpenUrl
4. 4.↵
   2. Kerdiles YM,
   3. Stone EL,
   4. Beisner DL,
   5. McGargill MA,
   6. Ch’en IL,
   7. Stockmann CS, et al.

   Foxo transcription factors control regulatory T cell development and function. Immunity. 2010; 33: 890–904.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   2. Wang X,
   3. Lang M,
   4. Zhao T,
   5. Feng X,
   6. Zheng C,
   7. Huang C, et al.

   Cancer-FOXP3 directly activated CCL5 to recruit FOXP3Treg cells in pancreatic ductal adenocarcinoma. Oncogene. 2017; 36: 3048–58.

   OpenUrl
6. 6.↵
   2. Huang C,
   3. Li Z,
   4. Li N,
   5. Li Y,
   6. Chang A,
   7. Zhao T, et al.

   Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice. Gastroenterology. 2018; 154: 675–88.

   OpenUrlCrossRefPubMed
7. 7.↵
   2. Zhao T,
   3. Jiang W,
   4. Wang X,
   5. Wang H,
   6. Zheng C,
   7. Li Y, et al.

   ESE3 inhibits pancreatic cancer metastasis by upregulating E-cadherin. Cancer Res. 2017; 77: 874–85.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   2. Liu J,
   3. Jiang W,
   4. Zhao K,
   5. Wang H,
   6. Zhou T,
   7. Bai W, et al.

   Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma. J Exp Med. 2019; 216: 656–73.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   2. Lytle NK,
   3. Ferguson LP,
   4. Rajbhandari N,
   5. Gilroy K,
   6. Fox RG,
   7. Deshpande A, et al.

   A multiscale map of the stem cell state in pancreatic adenocarcinoma. Cell. 2019; 177: 572–86.e22.

   OpenUrlCrossRefPubMed
10. 10.↵
    2. Li X,
    3. Xu Z,
    4. Du W,
    5. Zhang Z,
    6. Wei Y,
    7. Wang H, et al.

    Aiolos promotes anchorage independence by silencing p66Shc transcription in cancer cells. Cancer Cell. 2014; 25: 575–89.

    OpenUrlCrossRefPubMed
11. 11.↵
    2. Du W,
    3. Xu X,
    4. Niu Q,
    5. Zhang X,
    6. Wei Y,
    7. Wang Z, et al.

    Spi-B-mediated silencing of Claudin-2 promotes early dissemination of lung cancer cells from primary tumors. Cancer Res. 2017; 77: 4809–22.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    2. Jin S,
    3. Li R,
    4. Chen MY,
    5. Yu C,
    6. Tang LQ,
    7. Liu YM, et al.

    Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res. 2020; 30: 950–65.

    OpenUrlCrossRefPubMed